[ { "publication_date": "2025-11-26", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Magnus Olafsson Corfitzen", "person_in_leading_position": "Magnus Olafsson Corfitzen", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Tilldelning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2025-11-25", "volume": 24975.0, "volume_raw": "24975,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-11-26", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Tilldelning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2025-11-25", "volume": 1754.0, "volume_raw": "1754,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-09-23", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2025-09-23", "volume": 8000.0, "volume_raw": "8000,0", "volume_unit": "Antal", "price": 3.525, "price_raw": "3,525", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 28200.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-09-23", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2025-09-23", "volume": 15000.0, "volume_raw": "15000,0", "volume_unit": "Antal", "price": 3.56, "price_raw": "3,56", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 53400.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-22", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Marie Birgitta Källström", "person_in_leading_position": "Marie Birgitta Källström", "position": "Annan ledande befattningshavare", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsoption", "instrument_name": "ACE TO 1", "isin": "SE0022725438", "transaction_date": "2025-04-22", "volume": 18752.0, "volume_raw": "18752,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 40316.799999999996, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-22", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Marie Birgitta Källström", "person_in_leading_position": "Marie Birgitta Källström", "position": "Annan ledande befattningshavare", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen ökning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB ACE", "isin": "SE0010573113", "transaction_date": "2025-04-22", "volume": 18752.0, "volume_raw": "18752,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 40316.799999999996, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-28", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "KIBEGEON", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "Ja", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen ökning", "category": "other", "instrument_type": "Warrant", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2025-04-15", "volume": 92304.0, "volume_raw": "92304,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 198453.6, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-22", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Carin Linde", "person_in_leading_position": "Carin Linde", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsoption", "instrument_name": "ACE TO 1", "isin": "SE0022725438", "transaction_date": "2025-04-15", "volume": 40328.0, "volume_raw": "40328,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-22", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Carin Linde", "person_in_leading_position": "Carin Linde", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen ökning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2025-04-15", "volume": 40328.0, "volume_raw": "40328,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 86705.2, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-21", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsoption", "instrument_name": "ACE TO 1", "isin": "SE0022725438", "transaction_date": "2025-04-15", "volume": 18000.0, "volume_raw": "18000,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-21", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen ökning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB ACE", "isin": "SE0010573113", "transaction_date": "2025-04-15", "volume": 18000.0, "volume_raw": "18000,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 38700.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-17", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen ökning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB ACE", "isin": "SE0010573113", "transaction_date": "2025-04-15", "volume": 21688.0, "volume_raw": "21688,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 46629.2, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-17", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen ökning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB ACE", "isin": "SE0010573113", "transaction_date": "2025-04-15", "volume": 50000.0, "volume_raw": "50000,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 107500.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-17", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen ökning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB ACE", "isin": "SE0010573113", "transaction_date": "2025-04-15", "volume": 20472.0, "volume_raw": "20472,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 44014.799999999996, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-17", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen ökning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB ACE", "isin": "SE0010573113", "transaction_date": "2025-04-15", "volume": 6152.0, "volume_raw": "6152,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 13226.8, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-17", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Warrant", "instrument_name": "ACE TO 1", "isin": "SE0022725438", "transaction_date": "2025-04-15", "volume": 21688.0, "volume_raw": "21688,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 46629.2, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-17", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Warrant", "instrument_name": "ACE TO 1", "isin": "SE0022725438", "transaction_date": "2025-04-15", "volume": 50000.0, "volume_raw": "50000,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 107500.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-17", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Warrant", "instrument_name": "ACE TO 1", "isin": "SE0022725438", "transaction_date": "2025-04-15", "volume": 20472.0, "volume_raw": "20472,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 44014.799999999996, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-16", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Jennie Wilborgsson", "person_in_leading_position": "Jennie Wilborgsson", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Warrant", "instrument_name": "ACE TO 1", "isin": "SE0022725438", "transaction_date": "2025-04-15", "volume": 10000.0, "volume_raw": "10000,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-16", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Jennie Wilborgsson", "person_in_leading_position": "Jennie Wilborgsson", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen ökning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB ACE", "isin": "SE0010573113", "transaction_date": "2025-04-15", "volume": 10000.0, "volume_raw": "10000,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 21500.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-16", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Magnus Olafsson Corfitzen", "person_in_leading_position": "Magnus Olafsson Corfitzen", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsoption", "instrument_name": "ACE TO 1", "isin": "SE0022725438", "transaction_date": "2025-04-15", "volume": 100000.0, "volume_raw": "100000,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-04-16", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Magnus Olafsson Corfitzen", "person_in_leading_position": "Magnus Olafsson Corfitzen", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen ökning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2025-04-15", "volume": 100000.0, "volume_raw": "100000,0", "volume_unit": "Antal", "price": 2.15, "price_raw": "2,15", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 215000.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-03-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Carin Linde", "person_in_leading_position": "Carin Linde", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "Ja", "correction_description": "Rättat stavfel i namn på emittent.", "first_report": "", "share_program": "Ja", "character": "Tilldelning", "category": "other", "instrument_type": "Option", "instrument_name": "Personaloptioner serie 2025/2026 i Ascelia Pharma AB", "isin": "", "transaction_date": "2025-02-25", "volume": 440000.0, "volume_raw": "440000,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-03-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Marie Birgitta Källström", "person_in_leading_position": "Marie Birgitta Källström", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Tilldelning", "category": "other", "instrument_type": "Option", "instrument_name": "Personal optioner serie 2024/2025 Ascelia Pharma AB", "isin": "", "transaction_date": "2025-02-25", "volume": 44000.0, "volume_raw": "44000,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-02-28", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Magnus Olafsson Corfitzen", "person_in_leading_position": "Magnus Olafsson Corfitzen", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Tilldelning", "category": "other", "instrument_type": "Option", "instrument_name": "Personaloptioner serie 2025/2026 i Ascelia Pharma AB", "isin": "", "transaction_date": "2025-02-25", "volume": 990000.0, "volume_raw": "990000,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-02-27", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Jennie Wilborgsson", "person_in_leading_position": "Jennie Wilborgsson", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Tilldelning", "category": "other", "instrument_type": "Option", "instrument_name": "Personaloptioner serie 2025/2026 i Ascelia Pharma AB", "isin": "", "transaction_date": "2025-02-25", "volume": 440000.0, "volume_raw": "440000,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-02-27", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Tilldelning", "category": "other", "instrument_type": "Option", "instrument_name": "Personaloptioner serie 2025/2026 i Ascelia Pharma AB", "isin": "", "transaction_date": "2025-02-25", "volume": 825000.0, "volume_raw": "825000,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-02-27", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Tilldelning", "category": "other", "instrument_type": "Option", "instrument_name": "Personaloptioner serie 2025/2026 i Ascelia Pharma AB", "isin": "", "transaction_date": "2025-02-25", "volume": 660000.0, "volume_raw": "660000,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-12-09", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Annan ledande befattningshavare", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Tilldelning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-12-06", "volume": 1032.0, "volume_raw": "1032,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-12-09", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Magnus Olafsson Corfitzen", "person_in_leading_position": "Magnus Olafsson Corfitzen", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Tilldelning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-12-05", "volume": 11100.0, "volume_raw": "11100,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-12-09", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Tilldelning", "category": "other", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-12-05", "volume": 7770.0, "volume_raw": "7770,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-11-08", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-11-08", "volume": 20000.0, "volume_raw": "20000,0", "volume_unit": "Antal", "price": 2.731, "price_raw": "2,731", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 54620.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-11", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Helena Wennerström", "person_in_leading_position": "Helena Wennerström", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-10", "volume": 1280.0, "volume_raw": "1280,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 6489.6, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-09", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-09", "volume": 50000.0, "volume_raw": "50000,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 253500.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-11", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Jennie Wilborgsson", "person_in_leading_position": "Jennie Wilborgsson", "position": "Annan ledande befattningshavare", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-06", "volume": 15180.0, "volume_raw": "15180,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 76962.6, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-10", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Arbetstagarrepresentant i styrelsen eller arbetstagarsuppleant", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-06", "volume": 29700.0, "volume_raw": "29700,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 150579.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-09", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Carin Linde", "person_in_leading_position": "Carin Linde", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "Ja", "correction_description": "Korrigering av \"finansiellt instrument\" pga felsrkivning.", "first_report": "", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-04", "volume": 65533.0, "volume_raw": "65533,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-09", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Carin Linde", "person_in_leading_position": "Carin Linde", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "Ja", "correction_description": "Korrigering av \"finansiellt instrument\" pga felsrkivning.", "first_report": "", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE UR", "isin": "SE0022725461", "transaction_date": "2024-09-04", "volume": 40328.0, "volume_raw": "40328,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 204462.96000000002, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Carin Linde", "person_in_leading_position": "Carin Linde", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-04", "volume": 65533.0, "volume_raw": "65533,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Carin Linde", "person_in_leading_position": "Carin Linde", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "5493002YR9VCJJPWYN08", "isin": "SE0022725461", "transaction_date": "2024-09-04", "volume": 40328.0, "volume_raw": "40328,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 204462.96000000002, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "Ja", "correction_description": "Number of rights used adjusted", "first_report": "", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-04", "volume": 53989.0, "volume_raw": "53989,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "Ja", "correction_description": "Number of rights used adjusted", "first_report": "", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-04", "volume": 10114.0, "volume_raw": "10114,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "Ja", "correction_description": "Number of rights used adjusted", "first_report": "", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-04", "volume": 33224.0, "volume_raw": "33224,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 168445.68000000002, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "Ja", "correction_description": "Number of rights used adjusted", "first_report": "", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-04", "volume": 6224.0, "volume_raw": "6224,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 31555.68, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-04", "volume": 54000.0, "volume_raw": "54000,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-04", "volume": 10114.0, "volume_raw": "10114,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-04", "volume": 33224.0, "volume_raw": "33224,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 168445.68000000002, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Julie Brogren", "person_in_leading_position": "Julie Brogren", "position": "Vice VD", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-04", "volume": 6224.0, "volume_raw": "6224,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 31555.68, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-24", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "KIBEGEON", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "Ja", "correction": "Ja", "correction_description": "korrigereing af nærtstående og ISIN-kod", "first_report": "", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 913545.0, "volume_raw": "913545,0", "volume_unit": "Antal", "price": 0.1652, "price_raw": "0,1652", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 150917.63400000002, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-24", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Niels Mengel", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "", "correction": "Ja", "correction_description": "korrektion af type av finansielt instrument", "first_report": "", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 10493.0, "volume_raw": "10493,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-24", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Niels Mengel", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "", "correction": "Ja", "correction_description": "korrektion af type av finansielt instrument", "first_report": "", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 6456.0, "volume_raw": "6456,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 32731.920000000002, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-07", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Niels Mengel", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "", "correction": "Ja", "correction_description": "Has been reportet once on August the 29th 2024", "first_report": "", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-09-03", "volume": 131965.0, "volume_raw": "131965,0", "volume_unit": "Antal", "price": 0.135, "price_raw": "0,1350", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 17815.275, "status": "Makulerad", "is_current_report": true }, { "publication_date": "2024-09-07", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 923.0, "volume_raw": "923,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-07", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 568.0, "volume_raw": "568,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 2879.76, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-07", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 1573.0, "volume_raw": "1573,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-07", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 968.0, "volume_raw": "968,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 4907.76, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-07", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 5928.0, "volume_raw": "5928,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-07", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 3648.0, "volume_raw": "3648,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 18495.36, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-07", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 7826.0, "volume_raw": "7826,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-07", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Andreas Linderoth Norlin", "person_in_leading_position": "Andreas Linderoth Norlin", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 4816.0, "volume_raw": "4816,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 24417.120000000003, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "KIBEGEON", "person_in_leading_position": "KIBEGEON", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-09-03", "volume": 913545.0, "volume_raw": "913545,0", "volume_unit": "Antal", "price": 0.1652, "price_raw": "0,1652", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 150917.63400000002, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Niels Mengel", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-09-03", "volume": 131965.0, "volume_raw": "131965,0", "volume_unit": "Antal", "price": 0.135, "price_raw": "0,1350", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 17815.275, "status": "Makulerad", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Niels Mengel", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "BTA (betald tecknad aktie)", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 10493.0, "volume_raw": "10493,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Niels Mengel", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 6456.0, "volume_raw": "6456,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "EUR", "trading_venue": "Utanför handelsplats", "transaction_value": 32731.920000000002, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Niels Mengel", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "Ja", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 23256.0, "volume_raw": "23256,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 117907.92000000001, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Niels Mengel", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "Ja", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 37791.0, "volume_raw": "37791,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "KIBEGEON", "person_in_leading_position": "KIBEGEON", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 92304.0, "volume_raw": "92304,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 467981.28, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "KIBEGEON", "person_in_leading_position": "KIBEGEON", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 150000.0, "volume_raw": "150000,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Jennie Wilborgsson", "person_in_leading_position": "Jennie Wilborgsson", "position": "Annan ledande befattningshavare", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 7774.0, "volume_raw": "7774,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Jennie Wilborgsson", "person_in_leading_position": "Jennie Wilborgsson", "position": "Annan ledande befattningshavare", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 4784.0, "volume_raw": "4784,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 24254.88, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Marie Birgitta Källström", "person_in_leading_position": "Marie Birgitta Källström", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 2640.0, "volume_raw": "2640,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Marie Birgitta Källström", "person_in_leading_position": "Marie Birgitta Källström", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 984.0, "volume_raw": "984,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Marie Birgitta Källström", "person_in_leading_position": "Marie Birgitta Källström", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 6160.0, "volume_raw": "6160,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Marie Birgitta Källström", "person_in_leading_position": "Marie Birgitta Källström", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 1600.0, "volume_raw": "1600,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Magnus Olafsson Corfitzen", "person_in_leading_position": "Magnus Olafsson Corfitzen", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "Ascelia Pharma AB", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 162500.0, "volume_raw": "162500,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-06", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Magnus Olafsson Corfitzen", "person_in_leading_position": "Magnus Olafsson Corfitzen", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 100000.0, "volume_raw": "100000,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 507000.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "Ja", "correction_description": "fel ifyllt finansiellt instrument", "first_report": "", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE TR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 35243.0, "volume_raw": "35243,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "Ja", "correction_description": "fel ifyllt finansiellt instrument", "first_report": "", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE TR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 33267.0, "volume_raw": "33267,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "Ja", "correction_description": "fel ifyllt finansiellt instrument", "first_report": "", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE TR", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 9997.0, "volume_raw": "9997,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 21688.0, "volume_raw": "21688,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 109958.16, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 20472.0, "volume_raw": "20472,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 103793.04000000001, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-03", "volume": 6152.0, "volume_raw": "6152,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 31190.640000000003, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE BTU", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 35243.0, "volume_raw": "35243,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE BTU", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 33267.0, "volume_raw": "33267,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Peter Benson", "person_in_leading_position": "Peter Benson", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE BTU", "isin": "SE0022725453", "transaction_date": "2024-09-03", "volume": 9997.0, "volume_raw": "9997,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Helena Wennerström", "person_in_leading_position": "Helena Wennerström", "position": "Styrelseledamot", "closely_associated": "", "correction": "Ja", "correction_description": "Fel ISIN-kod samt beskrivning av finansiellt instrument", "first_report": "", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-02", "volume": 13536.0, "volume_raw": "13536,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 68627.52, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Helena Wennerström", "person_in_leading_position": "Helena Wennerström", "position": "Styrelseledamot", "closely_associated": "", "correction": "Ja", "correction_description": "Fel ISIN-kod samt beskrivning av finansiellt instrument", "first_report": "", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-02", "volume": 21996.0, "volume_raw": "21996,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Helena Wennerström", "person_in_leading_position": "Helena Wennerström", "position": "Styrelseledamot", "closely_associated": "", "correction": "Ja", "correction_description": "Fel ISIN-kod samt beskrivning av finansiellt instrument", "first_report": "", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "ACE BTU", "isin": "SE0022725461", "transaction_date": "2024-09-02", "volume": 4920.0, "volume_raw": "4920,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 24944.4, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-05", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Helena Wennerström", "person_in_leading_position": "Helena Wennerström", "position": "Styrelseledamot", "closely_associated": "", "correction": "Ja", "correction_description": "Fel ISIN-kod samt beskrivning av finansiellt instrument", "first_report": "", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "ACE UR", "isin": "SE0022725453", "transaction_date": "2024-09-02", "volume": 7995.0, "volume_raw": "7995,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Helena Wennerström", "person_in_leading_position": "Helena Wennerström", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-09-02", "volume": 13536.0, "volume_raw": "13536,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 68627.52, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Helena Wennerström", "person_in_leading_position": "Helena Wennerström", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-09-02", "volume": 21996.0, "volume_raw": "21996,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Helena Wennerström", "person_in_leading_position": "Helena Wennerström", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Teckning", "category": "other", "instrument_type": "BTU (betald tecknad unit)", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-09-02", "volume": 4920.0, "volume_raw": "4920,0", "volume_unit": "Antal", "price": 5.07, "price_raw": "5,07", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 24944.4, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-04", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Helena Wennerström", "person_in_leading_position": "Helena Wennerström", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Lösen minskning", "category": "other", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-09-02", "volume": 7995.0, "volume_raw": "7995,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,00", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-09-03", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Magnus Olafsson Corfitzen", "person_in_leading_position": "Magnus Olafsson Corfitzen", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "Ascelia Pharma AB", "isin": "SE0022725453", "transaction_date": "2024-08-29", "volume": 112645.0, "volume_raw": "112645,0", "volume_unit": "Antal", "price": 0.049405, "price_raw": "0,049405", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 5565.226224999999, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-09-07", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Niels Mengel", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "", "correction": "Ja", "correction_description": "Should bee reported under KIBEGEON which was not possible at that time, but now it is as A003H306", "first_report": "", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-08-26", "volume": 131965.0, "volume_raw": "131965,0", "volume_unit": "Antal", "price": 0.135, "price_raw": "0,1350", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 17815.275, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-08-29", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Niels Mengel", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-08-26", "volume": 131965.0, "volume_raw": "131965,0", "volume_unit": "Antal", "price": 0.135, "price_raw": "0,1350", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 17815.275, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2024-08-29", "issuer": "Ascelia Pharma AB", "lei": "5493002YR9VCJJPWYN08", "reporting_person": "Niels Mengel", "person_in_leading_position": "Niels Mengel", "position": "Styrelseledamot", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Teckningsrätt/Uniträtt", "instrument_name": "Ascelia Pharma AB", "isin": "SE0010573113", "transaction_date": "2024-08-26", "volume": 913965.0, "volume_raw": "913965,0", "volume_unit": "Antal", "price": 0.1652, "price_raw": "0,1652", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 150987.018, "status": "Reviderad", "is_current_report": true } ]